Stocktoria
IQVIA HOLDINGS INC. IQV
NYSE · XNYS · stock · Services-Commercial Physical & Biological Research · website · IPO 2013-05-09
IQVIA HOLDINGS INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $16.3B | $15.4B | $15.0B | $14.4B | $13.9B |
| SG&A expense | $2.0B | $2.0B | $2.1B | $2.1B | $2.0B |
| Operating income | $2.2B | $2.2B | $2.0B | $1.8B | $1.4B |
| Interest expense | $729.0M | $670.0M | $672.0M | $416.0M | $375.0M |
| Income tax | $252.0M | $301.0M | $101.0M | $260.0M | $163.0M |
| Net income | $1.4B | $1.4B | $1.4B | $1.1B | $966.0M |
| EPS (diluted) | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 |
| Operating cash flow | $2.7B | $2.7B | $2.1B | $2.3B | $2.9B |
| Cash & equivalents | $2.0B | $1.7B | $1.4B | $1.2B | $1.4B |
| Total assets | $29.9B | $26.9B | $26.7B | $25.3B | $24.7B |
| Total liabilities | $23.3B | $20.8B | $20.6B | $19.6B | $18.6B |
| Shareholders' equity | $6.6B | $6.1B | $6.1B | $5.8B | $6.0B |
Source: SEC EDGAR filings · CIK 0001478242 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.